EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tau‐mediated synaptic dysfunction is coupled with HCN channelopathy

Despoina Goniotaki iD, Francesco Tamagnini, Luca Biasetti, Svenja-Lotta Rumpf, Claire Troakes, Saskia J Pollack, Shalom Ukwesa, Haoyue Sun, Igor Kraev, Louise C Serpell, Wendy Noble, Kevin Staras und 1 weitere

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.14074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Despoina Goniotaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King…. Hauptthemen laut MEDLINE: Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Hippocampus, tau Proteins, Alzheimer Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Society, Biotechnology and Biological Sciences Research Council, Alzheimer's Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION In tauopathies, altered tau processing correlates with impairments in synaptic density and function. Changes in hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels contribute to disease‐associated abnormalities in multiple neurodegenerative diseases. METHODS To investigate the link between tau and HCN channels, we performed histological, biochemical, ultrastructural, and functional analyses of hippocampal tissues from Alzheimer's disease (AD), age‐matched controls, Tau35 mice, and/or Tau35 primary hippocampal neurons. RESULTS Expression of specific HCN channels is elevated in post mortem AD hippocampus. Tau35 mice develop progressive abnormalities including increased phosphorylated tau, enhanced HCN channel expression, decreased dendritic branching, reduced synapse density, and vesicle clustering defects. Tau35 primary neurons show increased HCN channel expression enhanced hyperpolarization‐induced membrane voltage “sag” and changes in the frequency and kinetics of spontaneous excitatory postsynaptic currents. DISCUSSION Our findings are consistent with a model in which pathological changes in tauopathies impact HCN channels to drive network‐wide structural and functional synaptic deficits. Highlights Hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels are functionally linked to the development of tauopathy. Expression of specific HCN channels is elevated in the hippocampus in Alzheimer's disease and the Tau35 mouse model of tauopathy. Increased expression of HCN channels in Tau35 mice is accompanied by hyperpolarization‐induced membrane voltage “sag” demonstrating a detrimental effect of tau abnormalities on HCN channel function. Tau35 expression alters synaptic organization, causing a loosened vesicle clustering phenotype in Tau35 mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsHippocampustau ProteinsAlzheimer DiseaseMice, TransgenicSynapsesAnimalsHumansMiceNeuronsChannelopathiesMaleFemaleAgedDisease Models, AnimalTauopathies

Stichwörter der Autor:innen

dementiahyperpolarization‐activated cyclic nucleotide‐gated channelsneurodegenerationsag voltagesynapsestauopathies

Substanzen

Hyperpolarization-Activated Cyclic Nucleotide-Gated Channelstau Proteins

Autor:innen und Institutionen

  • Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
  • Department of Pharmacy, School of Chemistry, Food and Pharmacy, University of Reading, Reading, UK.
  • Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.
  • Electron Microscopy Suite, STEM Faculty, The Open University, Milton Keynes, UK.
  • Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.

ORCID-Profile: Despoina Goniotaki, Diane P Hanger

Förderung

  • Alzheimer's Society
  • Biotechnology and Biological Sciences Research Council
  • Alzheimer's Research UK
  • Wellcome Trust

Zitieren

APA

Goniotaki, D., Tamagnini, F., Biasetti, L., Rumpf, S. L., Troakes, C., Pollack, S. J., Ukwesa, S., Sun, H., Kraev, I., Serpell, L. C., Noble, W., Staras, K., & Hanger, D. P. (2024). Tau‐mediated synaptic dysfunction is coupled with HCN channelopathy. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14074

Vancouver

Goniotaki D, Tamagnini F, Biasetti L, Rumpf SL, Troakes C, Pollack SJ, et al. Tau‐mediated synaptic dysfunction is coupled with HCN channelopathy. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14074

BibTeX
@article{Goniotaki2024,
  author = {Goniotaki, Despoina and Tamagnini, Francesco and Biasetti, Luca and Rumpf, Svenja-Lotta and Troakes, Claire and Pollack, Saskia J and Ukwesa, Shalom and Sun, Haoyue and Kraev, Igor and Serpell, Louise C and Noble, Wendy and Staras, Kevin and Hanger, Diane P},
  title = {Tau‐mediated synaptic dysfunction is coupled with HCN channelopathy},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.14074}
}
Kostenlos starten →